EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Role of Medical Therapy Before and After Balloon Pulmonary Angioplasty: CTEPH AC Registry Across Japan

Miki Sakamoto-Iwata, Yu Taniguchi iD, Kohei Masaki iD, Kazuya Hosokawa iD, Shiro Adachi iD, Takumi Inami iD, Jun Yamashita iD, Hitoshi Ogino, Masaru Hatano, Ichizo Tsujino, Nobuhiro Yaoita, Nobutaka Ikeda iD und 12 weitere

Pulmonary Circulation · 2026-07 · 16 (3)

DOI: 10.1002/pul2.70377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Circulation, online erschienen am 31.07.2026. Verfasst von Miki Sakamoto-Iwata und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine Kobe University Graduate School of Medicine Kobe Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to evaluate the role of medical therapy before and after balloon pulmonary angioplasty (BPA) for non‐operable chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era. This Japanese nationwide, multicenter, prospective observational registry, including 37 centers, analyzed data newly registered from August 2018–December 2023. Pretreatment before BPA was analyzed in patients who were treatment naïve or received medical therapy only at registration ( n = 557). De‐escalation or escalation of medical therapy after BPA was analyzed in patients who underwent BPA ( n = 966). The BPA pretreatment analysis in 557 patients showed that approximately 70% of the patients received medical therapy, of which 18% received combination therapy. Patients who received monotherapy or combination therapy had more severe baseline hemodynamics than those who did not. The 3‐year survival did not significantly differ between the no, mono, and combination pretreatment groups (94%, 98%, and 97%, respectively; p = 0.852). The BPA post‐treatment analysis in 966 patients showed that 20% of patients underwent de‐escalation of medical therapy. Patients with de‐escalation of medical therapy had lower mean pulmonary artery pressure (PAP) (20.9 ± 5.8 vs. 24.1 ± 7.3 mmHg, p < 0.01); however, they had a lower cardiac index at last follow‐up compared to patients without de‐escalation (2.66 ± 0.61 vs. 2.84 ± 0.70 L/min/m 2 , p = 0.01). Patients with severe disease tended to undergo pre‐treatment before BPA; however, patient survival did not differ across pretreatment types. De‐escalation of medical therapy after BPA can affect cardiac index. Therefore, de‐escalation or continuation of medical therapy should be carefully considered even after mean PAP normalizes after BPA.

Schlagwörter

Stichwörter der Autor:innen

Chronic thromboembolic pulmonary hypertensionballoon pulmonary angioplastymedical therapymultimodal therapypretreatment

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine Kobe University Graduate School of Medicine Kobe Japan.
  • Department of Cardiovascular Medicine Kyushu University Graduate School of Medical Sciences Fukuoka Japan.
  • Department of Cardiology Nagoya University Hospital Nagoya Japan.
  • Department of Cardiovascular Medicine Kyorin University School of Medicine Tokyo Japan.
  • Department of Cardiology Tokyo Medical University Tokyo Japan.
  • Department of Cardiovascular Surgery Medical Research Institute Kitano Hospital Osaka Japan.

ORCID-Profile: Yu Taniguchi, Kohei Masaki, Kazuya Hosokawa, Shiro Adachi, Takumi Inami, Jun Yamashita, Nobutaka Ikeda, Hiroto Shimokawahara, Nobuhiro Tanabe, Kayoko Kubota, Yoshito Ogihara, Koshin Horimoto, Yoshihiro Dohi, Takahiro Hiraide, Yuichi Tamura, Yoshihiro Fukumoto

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Sakamoto-Iwata, M., Taniguchi, Y., Masaki, K., Hosokawa, K., Adachi, S., Inami, T., Yamashita, J., Ogino, H., Hatano, M., Tsujino, I., Yaoita, N., Ikeda, N., Shimokawahara, H., Tanabe, N., Kubota, K., Shigeta, A., Ogihara, Y., Horimoto, K., Dohi, Y., …, & Abe, K. (2026). The Role of Medical Therapy Before and After Balloon Pulmonary Angioplasty: CTEPH AC Registry Across Japan. Pulmonary Circulation, 16(3). https://doi.org/10.1002/pul2.70377

Vancouver

Sakamoto-Iwata M, Taniguchi Y, Masaki K, Hosokawa K, Adachi S, Inami T, et al. The Role of Medical Therapy Before and After Balloon Pulmonary Angioplasty: CTEPH AC Registry Across Japan. Pulmonary Circulation. 2026;16(3). doi:10.1002/pul2.70377

BibTeX
@article{SakamotoIwata2026,
  author = {Sakamoto-Iwata, Miki and Taniguchi, Yu and Masaki, Kohei and Hosokawa, Kazuya and Adachi, Shiro and Inami, Takumi and Yamashita, Jun and Ogino, Hitoshi and Hatano, Masaru and Tsujino, Ichizo and Yaoita, Nobuhiro and Ikeda, Nobutaka and Shimokawahara, Hiroto and Tanabe, Nobuhiro and Kubota, Kayoko and Shigeta, Ayako and Ogihara, Yoshito and Horimoto, Koshin and Dohi, Yoshihiro and Hiraide, Takahiro and Kawakami, Takashi and Tamura, Yuichi and Fukumoto, Yoshihiro and Abe, Kohtaro},
  title = {The Role of Medical Therapy Before and After Balloon Pulmonary Angioplasty: CTEPH AC Registry Across Japan},
  journal = {Pulmonary Circulation},
  year = {2026},
  volume = {16},
  number = {3},
  doi = {10.1002/pul2.70377}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche